|
Market Closed -
NYSE
16:00:02 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 24.41 USD | +2.43% |
|
-3.25% | +2.43% |
| 09-22 | Arcus Biosciences, Inc. Announces New Data for Casdatifan as Treatment for Kidney Cancer Across Multiple Lines of Therapy | CI |
| 09-16 | TD Cowen Initiates Arcus Biosciences at Buy | MT |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| RCUS | Delayed | |
CBOE
| RCUS | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 26.87 | 31.57 | 31 |
| Spread/Res. | -9.16% | -22.68% | -21.26% |
| Spread/Supp. | +2.43% | +10.35% | +0.21% |
| Support | 23.83 | 22.12 | 24.36 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RCUS Stock
- Charts Arcus Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
